AbbVie : ABBV

All AbbVie Articles

612 Articles

Lee Jackson | Aug 8, 2016 at 10:05 AM EDT

Jefferies Makes Another Big Summer Change to Its Franchise Picks List

In a recent research note, the analysts at Jefferies made a big move by adding Ball Corp. to the firm's…

Lee Jackson | Aug 5, 2016 at 10:20 AM EDT

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

A new Jefferies research report features the firm's top pharmaceutical stock picks in order of preference, and AbbVie stays in…

Chris Lange | Jul 29, 2016 at 9:05 AM EDT

How AbbVie Won Big on Earnings

AbbVie released a better-than-expected second-quarter earnings report before the markets opened on Friday.

Lee Jackson | Jul 29, 2016 at 8:15 AM EDT

Jefferies Makes Key Changes to Top Energy Stocks in Franchise Picks Portfolio

Despite the fact that energy has tumbled 20% from the highs posted in June, Jefferies remains bullish on the natural…

Chris Lange | Jul 28, 2016 at 9:45 AM EDT

Bristol-Myers Earnings Don’t Appear to Be Enough for Investors

Bristol-Myers Squibb released a better-than-expected second-quarter earnings report before the markets opened on Thursday.

Chris Lange | Jul 27, 2016 at 8:25 AM EDT

Short Sellers Get Selective on Major Pharma

The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest…

Lee Jackson | Jul 26, 2016 at 8:35 AM EDT

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

SunTrust Robinson Humphrey feels that the major pharmaceutical companies will outperform the rest of the year, and they cite new…

Douglas A. McIntyre | Jul 24, 2016 at 10:47 AM EDT

Apple Picked as World’s Favorite Company

In a study that ranks “perceived strength” of companies rather than their financial performance, Apple Inc. (NASDAQ: AAPL) took the top…

Chris Lange | Jul 24, 2016 at 10:12 AM EDT

10 Must-See Earnings for the Coming Week

24/7 Wall St. has put together a preview of Alphabet, Amazon.com, Facebook and some of the other major companies reporting…

Lee Jackson | Jul 16, 2016 at 9:15 AM EDT

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

With yields plunging and the market getting very pricey, some top pharmaceutical stocks are starting to look like a great…

Chris Lange | Jul 13, 2016 at 9:15 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Jul 3, 2016 at 7:38 AM EDT

How Major Pharma Is Faring After the Brexit

The broad markets are recovering in the wake of the Brexit and it really appears to be one big head…

Chris Lange | Jun 27, 2016 at 8:11 AM EDT

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a…

Chris Lange | Jun 15, 2016 at 11:05 AM EDT

6 Biopharma Movers Making a Run on Wednesday

24/7 Wall St. has picked out the biggest movers and winners on Wednesday, particularly biopharma companies making serious runs in…

Chris Lange | Jun 14, 2016 at 11:15 AM EDT

Why Infinity Pharmaceuticals Crashed

Though Infinity Pharmaceuticals announced that its DYNAMO study met its primary endpoint of overall response rate, the stock was still…

1 … 29 30 31 32 33 … 41

AbbVie : ABBV

All AbbVie Articles

Jefferies Makes Another Big Summer Change to Its Franchise Picks List

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

How AbbVie Won Big on Earnings

Jefferies Makes Key Changes to Top Energy Stocks in Franchise Picks Portfolio

Bristol-Myers Earnings Don’t Appear to Be Enough for Investors

Short Sellers Get Selective on Major Pharma

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Apple Picked as World’s Favorite Company

10 Must-See Earnings for the Coming Week

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Short Sellers Run for Cover From Major Pharma

How Major Pharma Is Faring After the Brexit

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

6 Biopharma Movers Making a Run on Wednesday

Why Infinity Pharmaceuticals Crashed

4 Dividend Kings Are Crushing the S&P 500 in 2026 and Still Have Big Upside Potential

Korean Chip Stocks Are Trading Like The AI Bubble Has Burst. Is Micron Next?

Price Prediction: ON Semiconductor’s Rally May Be Far From Over

75-Year-Old With $1.3M Faces $58,000 RMD That Drags 85% of His Social Security Into Tax

The Real Risk in Retirement Isn't Running Out of Money. It's Losing Your Purchasing Power.

4 Dividend Kings Are Crushing the S&P 500 in 2026 and Still Have Big Upside Potential

Korean Chip Stocks Are Trading Like The AI Bubble Has Burst. Is Micron Next?

AbbVie : ABBV

All AbbVie Articles

Jefferies Makes Another Big Summer Change to Its Franchise Picks List

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

How AbbVie Won Big on Earnings

Jefferies Makes Key Changes to Top Energy Stocks in Franchise Picks Portfolio

Bristol-Myers Earnings Don’t Appear to Be Enough for Investors

Short Sellers Get Selective on Major Pharma

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Apple Picked as World’s Favorite Company

10 Must-See Earnings for the Coming Week

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Short Sellers Run for Cover From Major Pharma

How Major Pharma Is Faring After the Brexit

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

6 Biopharma Movers Making a Run on Wednesday

Why Infinity Pharmaceuticals Crashed

4 Dividend Kings Are Crushing the S&P 500 in 2026 and Still Have Big Upside Potential

Korean Chip Stocks Are Trading Like The AI Bubble Has Burst. Is Micron Next?

Price Prediction: ON Semiconductor’s Rally May Be Far From Over

Featured Reads

75-Year-Old With $1.3M Faces $58,000 RMD That Drags 85% of His Social Security Into Tax

The Real Risk in Retirement Isn't Running Out of Money. It's Losing Your Purchasing Power.